Transplantation, AutologousLymphoma, Large B-Cell, DiffuseHematopoietic Stem Cell TransplantationStem Cell TransplantationLymphoma, B-CellHodgkin DiseaseAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationMultiple MyelomaLymphoma, Non-HodgkinMelphalanTransplantation, HomologousTransplantation ConditioningVincristineTreatment OutcomeAntibodies, Monoclonal, Murine-DerivedCombined Modality TherapyCyclophosphamideLymphoma, FollicularRemission InductionDoxorubicinProto-Oncogene Proteins c-bcl-6PrednisoneSalvage TherapyDisease-Free SurvivalStem CellsGerminal CenterEtoposidePrognosisRecurrenceLymphomaRetrospective StudiesCytarabineMyeloablative AgonistsSurvival RateCarmustineSurvival AnalysisHematopoietic Stem Cell MobilizationBone Marrow TransplantationGraft vs Host DiseaseThiotepaChemotherapy-Induced Febrile NeutropeniaBone Marrow PurgingHematologic NeoplasmsLymphoma, T-Cell, PeripheralLymphoma, Mantle-CellFatal OutcomeWhole-Body IrradiationAmyloidosisHematopoietic Stem CellsB-LymphocytesBoronic AcidsDexamethasoneEpstein-Barr Virus InfectionsBusulfanPyrazinesLymphoproliferative DisordersTranslocation, GeneticFollow-Up StudiesGraft SurvivalLymphoma, B-Cell, Marginal ZoneAntineoplastic Agents, AlkylatingCARD Signaling Adaptor ProteinsAntineoplastic AgentsAntigens, CD34AutograftsIfosfamideThalidomideLiver TransplantationTime FactorsInduction ChemotherapyImmunohistochemistryMesenchymal Stem Cell TransplantationGranulocyte Colony-Stimulating FactorPodophyllotoxinLeukapheresisTransplantation ChimeraNeoplasm, ResidualMaintenance ChemotherapyTissue DonorsLeukemia, Myeloid, AcuteCord Blood Stem Cell TransplantationNeoplasms, Second PrimaryCell TransplantationReed-Sternberg CellsAntibodies, MonoclonalCell Line, TumorKidney TransplantationMitoxantroneEnteropathy-Associated T-Cell LymphomaEmbryonic Stem CellsTumor Markers, BiologicalMyelodysplastic SyndromesImmunophenotypingGene Expression ProfilingIdarubicinLeukemia, Plasma CellCisplatinInfusions, SpinalProspective Studies